XML 20 R3.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 34,767 $ 238,940
Restricted cash, current 1,213 1,217
Accounts receivable, net 4,952 451
Accounts receivable, net - related parties 0 66
Short-Term Investments 105,047 0
Prepaid expenses and other current assets 5,657 4,844
Total current assets 151,636 245,518
Property and equipment, net 17,570 4,501
Operating lease right-of-use assets 3,401 0
Restricted cash, non-current 675 75
Other non-current assets 271 105
Total assets 173,553 250,199
Current liabilities:    
Accounts payable 3,036 1,572
Accrued and other current liabilities 14,125 6,487
Accrued product warranties 1,643 0
Operating lease liabilities, current 1,421 0
Deferred revenue 6,168 3,663
Notes payable, current 1,600 1,900
Total current liabilities 27,993 13,622
Notes payable, non-current 315 1,869
Operating lease liabilities, non-current 2,535 0
Deferred revenue, non-current 2,442 0
Earnout warrant liabilities 163 1,476
Public warrant liabilities 2,066 18,666
Private warrant liabilities 980 8,855
Other non-current liabilities 85 552
Total liabilities 36,579 45,040
Commitments and contingencies (Note 11)  
Stockholders’ equity:    
Preferred stock ($0.0001 par value, 200,000,000 shares authorized, none issued and outstanding as of December 31, 2022 and 2021) 0 0
Common stock ($0.0001 par value; 2,000,000,000 shares authorized, 153,821,339 and 151,839,058 shares issued and outstanding as of December 31, 2022 and 2021, respectively) 16 16
Additional paid-in capital 755,537 745,753
Accumulated deficit (618,579) (540,610)
Total stockholders’ equity 136,974 205,159
Total liabilities and stockholders’ equity $ 173,553 $ 250,199